Doctors at NCR are conducting a study for adults who are overweight and want to lose weight.  The study will evaluate a medication to determine how much weight a participant can lose in 1 1/2 years.  All participants will receive instruction from a research dietitian and support to follow a calorie-reduced diet.  The medication being tested in this study is called Semaglutide.  Semaglutide was approved by the FDA in June 2022 for weight loss.

18 or older

  • BMI over 30.0kg/m2
  • History of at least one unsuccessful dietary effort to lose body weight
  • Cannot be diabetic
  • No treatment with glucose lowering agents in the last 90 days
  • No treatment with other drugs in same class in last 180 days
  • No history of cancer in the last 5 years

18 months

You will be reimbursed up to $975 if you complete the study visits

Want to participate? Fill out the interest form! Click to Call Us!